UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Greatly improved heat-shielding performance of KxWO3 by trace Pt doping for energy-saving window glass applications

Solar energy materials and solar cells, 2018-01, Vol.174, p.342-350

2018

Volltextzugriff (PDF)

Enhanced electrochromic performance of KxWO3 by tailoring crystal structure and valence state

Solid state ionics, 2024-10, Vol.414, Article 116632

2024

Volltextzugriff (PDF)

Emicizumab-kxwh: First Global Approval

Drugs (New York, N.Y.), 2018-02, Vol.78 (2), p.269-274

2018

Volltextzugriff (PDF)

Optimizing maintenance dosing of emicizumab-kxwh as prophylaxis in hemophilia A: Dosing to product labeling while minimizing drug waste

Journal of managed care & specialty pharmacy, 2023-01, Vol.29 (1), p.47-57

2023

Volltextzugriff (PDF)

Emicizumab-Kxwh for Previously Untreated Patients with Haemophilia: The Conversation Begins

Blood, 2019-11, Vol.134 (Supplement_1), p.2409-2409

2019

Volltextzugriff (PDF)

Synthesis of near infrared-activatable KxWO3 nanorods for photothermal therapy

Materials letters, 2018-02, Vol.212, p.194-197

2018

Volltextzugriff (PDF)

Self-assembly of KxWO3 nanowires into nanosheets by an oriented attachment mechanism

ACS applied materials & interfaces, 2013-10, Vol.5 (20), p.10346-10351

2013

Volltextzugriff (PDF)

Experimental and theoretical investigation of a mesoporous KxWO3 material having superior mechanical strength

Nanoscale, 2016-02, Vol.8 (5)

2016

Volltextzugriff (PDF)

Experimental and theoretical investigation of a mesoporous KxWO3 material having superior mechanical strengthElectronic supplementary information (ESI) available: Experimental details of SEM and TEM measurements, SAXS data analysis, the procedure for Rietveld refinement, peak fitting for the Raman results, the modelling approach, UV-Vis and N2 sorption measurements. See DOI: 10.1039/c5nr07941a

2016-01

Volltextzugriff (PDF)

Charge Density Wave and Crystal Structure of KxWO3 (x=0.20 and 0.22) Prepared by Hybrid Microwave Method

Journal of low temperature physics, 2017-07, Vol.188 (1-2), p.1-10

2017

Volltextzugriff (PDF)

KxWO Is a Novel Ferroelectric Nanomaterial for Application as a Room Temperature Acetone Sensor

Nanomaterials (Basel, Switzerland), 2020-01, Vol.10 (2), p.225

2020

Volltextzugriff (PDF)

Emicizumab-kxwh

American journal of health-system pharmacy, 2018-01, Vol.75 (1), p.e2

2018

Volltextzugriff (PDF)

Growth, Structure, and Stability of KxWO3 Nanorods on Mica Substrate

Journal of physical chemistry. C, 2012-01, Vol.116 (2), p.1921-1929

2012

Volltextzugriff (PDF)

Dual functionality of K0.3WO3/Ag2O nanocomposites for smart window: Energy saving and visible photocatalytic self-cleaning performance

Solar energy materials and solar cells, 2019-07, Vol.196, p.111-118

2019

Volltextzugriff (PDF)

Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors

European journal of medicinal chemistry, 2021-03, Vol.213, p.113161, Article 113161

2021

Volltextzugriff (PDF)

Effect of morphology on the near infrared shielding property and thermal performance of K0.3WO3 blue pigments for smart window applications

Dyes and pigments, 2018-09, Vol.156, p.33-38

2018

Volltextzugriff (PDF)

The haemophilia drug market

Nature reviews. Drug discovery, 2018-08, Vol.17 (8), p.541-542

2018

Volltextzugriff (PDF)

Emicizumab for hemophilia A without inhibitors

Expert review of hematology, 2019-07, Vol.12 (7), p.515-524

2019

Volltextzugriff (PDF)

Emicizumab-kxwh: A Critical Review

International Undergraduate Journal of Health Sciences, 2022-06, Vol.2 (1)

O'Leary, Kiera

2022

Volltextzugriff (PDF)

Treatment investigated to prevent blood-clotting disorders: A new subcutaneous therapy could offer a promising solution to a bleeding disorder in both children and adults

Contemporary pediatrics (Montvale, N.J.), 2017-11, Vol.34 (11), p.20

Zimlich, Rachael

2017

Volltextzugriff (PDF)

FDA approves emicizumab-kxwh for hemophilia A with or without factor VIII inhibitors

Case Medical Research, 2018-10

U.S. Food & Drug Administration

2018

Volltextzugriff (PDF)

New Data Reinforce the Benefit of Early Preventative Treatment With Genentech’s Hemlibra (emicizumab-kxwh) for Babies With Severe hemophilia A

Business Wire, 2023

2023

Volltextzugriff (PDF)

FDA approves emicizumab-kxwh for prevention and reduction of bleeding in patients with hemophilia A with factor VIII inhibitors

Case Medical Research, 2017-11

U.S. Food & Drug Administration

2017

Volltextzugriff (PDF)

New product intros (benralizumab, dinutuximab beta, emicizumab-kxwh, evolocumab (new indication), latanoprostene bunod, mepolizumab (new indication), tofacitinib citrate (new indication), umeclidinium bromide/vilanterol trifenate/fluticasone furoate (new combination))

Drugs of Today, 2017, Vol.53 (12), p.671

2017

Volltextzugriff (PDF)

Interim Data From Phase III Study Presented at ASH 2022 Show Hemlibra (emicizumab-kxwh) Achieved Meaningful Bleed Control in Infants From Birth

Business Wire, 2022

2022

Volltextzugriff (PDF)

1 – 25 von 2.779

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.135)
Mit Volltextzugriff
(1.557)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

14 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(878)
Physical Sciences
(410)
Life Sciences & Biomedicine
(352)
Technology
(319)
Mathematics
(250)
Physics
(190)
Engineering
(174)
Hemophilia
(174)
Humans
(174)
Chemistry
(141)
Materials Science
(138)
Hematology
(97)
Computer Science
(94)
Materials Science, Multidisciplinary
(87)
Science & Technology - Other Topics
(74)
Algorithms
(72)
Statistics & Probability
(69)
Mathematical & Computational Biology
(67)
Mechanical Engineering
(67)
Patients
(65)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Greatly improved heat-shielding performance of KxWO3 by trace Pt doping for energy-saving window glass applications

Enhanced electrochromic performance of KxWO3 by tailoring crystal structure and valence state

Emicizumab-kxwh: First Global Approval

Optimizing maintenance dosing of emicizumab-kxwh as prophylaxis in hemophilia A: Dosing to product labeling while minimizing drug waste

Emicizumab-Kxwh for Previously Untreated Patients with Haemophilia: The Conversation Begins

Synthesis of near infrared-activatable KxWO3 nanorods for photothermal therapy

Self-assembly of KxWO3 nanowires into nanosheets by an oriented attachment mechanism

Experimental and theoretical investigation of a mesoporous KxWO3 material having superior mechanical strength

Charge Density Wave and Crystal Structure of KxWO3 (x=0.20 and 0.22) Prepared by Hybrid Microwave Method

KxWO Is a Novel Ferroelectric Nanomaterial for Application as a Room Temperature Acetone Sensor

Emicizumab-kxwh

Growth, Structure, and Stability of KxWO3 Nanorods on Mica Substrate

Dual functionality of K0.3WO3/Ag2O nanocomposites for smart window: Energy saving and visible photocatalytic self-cleaning performance

Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors

Effect of morphology on the near infrared shielding property and thermal performance of K0.3WO3 blue pigments for smart window applications

The haemophilia drug market

Emicizumab for hemophilia A without inhibitors

Emicizumab-kxwh: A Critical Review

Treatment investigated to prevent blood-clotting disorders: A new subcutaneous therapy could offer a promising solution to a bleeding disorder in both children and adults

FDA approves emicizumab-kxwh for hemophilia A with or without factor VIII inhibitors

New Data Reinforce the Benefit of Early Preventative Treatment With Genentech’s Hemlibra (emicizumab-kxwh) for Babies With Severe hemophilia A

FDA approves emicizumab-kxwh for prevention and reduction of bleeding in patients with hemophilia A with factor VIII inhibitors

New product intros (benralizumab, dinutuximab beta, emicizumab-kxwh, evolocumab (new indication), latanoprostene bunod, mepolizumab (new indication), tofacitinib citrate (new indication), umeclidinium bromide/vilanterol trifenate/fluticasone furoate (new combination))

Interim Data From Phase III Study Presented at ASH 2022 Show Hemlibra (emicizumab-kxwh) Achieved Meaningful Bleed Control in Infants From Birth

Suchergebnisse filtern